These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

218 related items for PubMed ID: 6140678

  • 1. Prorenin and beta-blockade in hypertension.
    McKenna F, Davison AM.
    Proc Eur Dial Transplant Assoc; 1983; 20():566-71. PubMed ID: 6140678
    [Abstract] [Full Text] [Related]

  • 2. Renin and beta-blockade: prorenin and aldosterone may explain the controversy.
    McKenna F, Davison AM.
    Clin Nephrol; 1986 Mar; 25(3):149-54. PubMed ID: 2869848
    [Abstract] [Full Text] [Related]

  • 3. Metoprolol in high renin hypertension. A comparison with propranolol.
    Lameyer LD, Hesse CJ.
    Ann Clin Res; 1981 Mar; 13 Suppl 30():16-22. PubMed ID: 7027889
    [Abstract] [Full Text] [Related]

  • 4. Relation between renin and prorenin in plasma from hypertensive patients and normal people: evidence for different renin:prorenin ratios.
    Leckie BJ, Morton JJ.
    J Hum Hypertens; 1995 Jun; 9(6):493-6. PubMed ID: 7473533
    [Abstract] [Full Text] [Related]

  • 5. Long term non-selective and cardioselective beta-receptor blockade in hypertensive patients. Effects on circulatory parameters, catecholamines and renin activity under basal conditions and in connection with exercise and hypoglycemia.
    Hansson BG.
    Acta Med Scand Suppl; 1976 Jun; 598():1-61. PubMed ID: 13611
    [No Abstract] [Full Text] [Related]

  • 6. [Hemodynamic changes under metoprolol compared to propranolol in hypertensive patients].
    Pfisterer M, Burkart F, Bühler FR, Schweizer W.
    Schweiz Med Wochenschr; 1976 Nov 06; 106(45):1567-9. PubMed ID: 1013675
    [Abstract] [Full Text] [Related]

  • 7. Initial therapy of essential hypertension: diuretic or beta blocker?
    Finnerty FA.
    J Fam Pract; 1980 Aug 06; 11(2):199-205. PubMed ID: 6106039
    [Abstract] [Full Text] [Related]

  • 8. Effects of beta 1-selective and non-selective beta-blockade on blood pressure, plasma renin activity and plasma aldosterone in hypertensive patients.
    van Herwaarden CL, Fennis JF, van 'T Laar A.
    Neth J Med; 1979 Aug 06; 22(1):17-22. PubMed ID: 368667
    [No Abstract] [Full Text] [Related]

  • 9. Plasma renin and "prorenin" in essential hypertension during sodium depletion, beta-blockade, and reduced arterial pressure.
    Atlas SA, Sealey JE, Laragh JH, Moon C.
    Lancet; 1977 Oct 15; 2(8042):785-9. PubMed ID: 71600
    [Abstract] [Full Text] [Related]

  • 10. [Our experience on the clinical use of nadolol].
    Trinchero R, Moratti M, Ghisio A, Pomari F, Artesani S, Barbano G.
    Minerva Cardioangiol; 1985 Oct 15; 33(10):629-34. PubMed ID: 2867492
    [No Abstract] [Full Text] [Related]

  • 11. Changes in plasma active renin and prorenin after endoscopic retrograde pancreatography.
    Higaki J, Okuno M, Nakamaru M, Morishita R, Himeno S, Ogihara T.
    Methods Find Exp Clin Pharmacol; 1989 Nov 15; 11(11):703-5. PubMed ID: 2695725
    [Abstract] [Full Text] [Related]

  • 12. A report on the clinical efficacy of nadolol--a new long acting beta-blocker.
    Hill LS, Fand RS.
    Ir Med J; 1979 Dec 15; 72(12):522-9. PubMed ID: 44273
    [No Abstract] [Full Text] [Related]

  • 13. [Determination of the inactive renin (prorenin) content in the blood plasma by a cryoactivation method].
    Uchitel' IA.
    Lab Delo; 1982 Dec 15; (5):301-3. PubMed ID: 6178890
    [No Abstract] [Full Text] [Related]

  • 14. Renin kinetics in hypertension: effect of propranolol and penbutolol.
    Hauger-Klevene JH, Levin GM.
    Medicina (B Aires); 1976 Dec 15; 36(3):212-8. PubMed ID: 9557
    [No Abstract] [Full Text] [Related]

  • 15. [Long-term administration of trimepranol in young men with labile borderline hypertension and its influence on plasma renin activity (author's transl)].
    Slabý A, Dosková M, Jirák R, Pavlát J, Urbánek J, Reisenauer R.
    Sb Lek; 1975 Apr 15; 77(4):107-11. PubMed ID: 238278
    [No Abstract] [Full Text] [Related]

  • 16. Mediation of blood pressure by nadolol and alpha methyldopa.
    Jenkins AC, Rosenthal J, Stumpe KO.
    Practitioner; 1981 Mar 15; 225(1353):405-9. PubMed ID: 6115378
    [No Abstract] [Full Text] [Related]

  • 17. Human prorenin: pathophysiology and clinical implications.
    Derkx FH, Schalekamp MA.
    Clin Exp Hypertens A; 1988 Mar 15; 10(6):1213-25. PubMed ID: 3066528
    [Abstract] [Full Text] [Related]

  • 18. Discordant beta-blocker effects on clinic, ambulatory, resting, and exercise hemodynamics in patients with hypertension.
    Beitelshees AL, Zineh I, Yarandi HN, Pauly DF, Johnson JA.
    Pharmacotherapy; 2006 Sep 15; 26(9):1247-54. PubMed ID: 16945046
    [Abstract] [Full Text] [Related]

  • 19. Nadolol, a once daily treatment for hypertension: multi-centre clinical evaluation.
    Jackson DA.
    Br J Clin Pract; 1980 Jul 15; 34(7):211-21. PubMed ID: 6107120
    [No Abstract] [Full Text] [Related]

  • 20. Plasma kallikrein and prorenin in patients with hereditary angioedema.
    Purdon AD, Schapira M, De Agostini A, Colman RW.
    J Lab Clin Med; 1985 Jun 15; 105(6):694-9. PubMed ID: 3889200
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.